
    
      Application of the BIIR gene expression profile approach to heart transplantation clinical
      diagnostic issues is likely to create new means to detect rejection at the earliest stages,
      to help prevent progression through earlier treatment, to discover new avenues targets for
      treatment of heart graft rejection, and to reduce the cost of post-transplant health care
    
  